Mentor, Ohio-based STERIS plc (STE) provides infection prevention products and services in the United States and internationally. The company has a market cap of $22.6 billion and operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences, and offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing systems and tracking products, endoscopy accessories, instruments, and more.
STE is expected to release its Q2 2027 earnings on Wednesday, November 4, 2026, after the market closes. Ahead of the event, analysts expect the company’s EPS to be $2.67 on a diluted basis, up 8.1% from $2.47 in the year-ago quarter. The company has met or exceeded Wall Street’s EPS estimates in three of its last four quarters, while missing on one occasion.